These results provide further evidence for a direct link between TDP-43 pathology and the UNC13A cryptic exon and raise the possibility that this exon could be developed into another biomarker for the majority of FTD and ALS cases. The gene discussed is TARDBP; the disease is frontotemporal dementia.